Quest Diagnostics (DGX) Total Non-Current Liabilities (2009 - 2026)

Quest Diagnostics has disclosed Total Non-Current Liabilities across 18 years of filings, most recently posting $8.1 billion for Q2 2026.

• In Q2 2026, Total Non-Current Liabilities rose 3.16% year-over-year to $8.1 billion; the TTM figure through Jun 2026 stood at $8.1 billion (up 3.16% YoY), while the FY2025 annual figure was $8.1 billion, down 4.05% from the prior year.
• Total Non-Current Liabilities came in at $8.1 billion for Q2 2026 at Quest Diagnostics, up from $8.0 billion in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $8.4 billion in Q4 2024 to a low of $5.9 billion in Q1 2023.
• Average Total Non-Current Liabilities over 5 years is $7.2 billion, with a median of $7.1 billion recorded in 2023.
• Year-over-year, Total Non-Current Liabilities dropped 6.17% in 2023 and soared 36.09% in 2024.
• Over 5 years, Total Non-Current Liabilities stood at $6.1 billion in 2022, then rose by 11.63% to $6.8 billion in 2023, then gained by 23.49% to $8.4 billion in 2024, then declined by 4.05% to $8.1 billion in 2025, then dropped by 0.01% to $8.1 billion in 2026.
• Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $8.1 billion in Q2 2026, $8.0 billion in Q1 2026, and $8.1 billion in Q4 2025.